Brief: BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results
10/11/2021 12:36
Nov 10 (Reuters) - BIONIK Laboratories Corp BNKL.PK :
* BIONIK LABORATORIES REPORTS SECOND QUARTER FISCAL YEAR
2022
FINANCIAL RESULTS
* Q2 REVENUE $200,000
* Q2 LOSS PER SHARE $0.21 EXCLUDING ITEMS
* Q2 LOSS PER SHARE $0.22
Source text for Eikon: ID:nBwBxSJma
Further company coverage: BNKL.PK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bionik Laboratories
See all newsBrief: Bionik Laboratories Reports A Significant Increase In Patient Volume At Its Acquired Rehabilitation Center In Florida
Brief: Bionik Laboratories Enters Into Distribution Agreement With Pro-Med Technology For The Sale Of Inmotion® Robotic Devices In Hong Kong
Brief: Bionik Laboratories acquires Florida Rehabilitation Center first in strategic national rollout
Brief: Bionik Laboratories Reports Q1 Revenue Of $200,000
Brief: Bionik Laboratories Says Chief Commercial Officer, Terminated Other Than For Cause From Employment, Officer Positions With Co, Units